8-K 1 b68622pie8vk.htm PAREXEL INTERNATIONAL CORPORATION e8vk
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 15, 2008
PAREXEL International Corporation
 
(Exact name of registrant as specified in charter)
         
Massachusetts   000-21244   04-2776269
 
(State or other juris-
diction of incorporation 		  (Commission
File Number) 		  (IRS Employer
Identification No.)
     
200 West Street, Waltham, Massachusetts   02451
 
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code: (781) 487-9900
Not applicable.
 
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations for the registrant under any of the following provisions (see General Instruction A.2. below):
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

TABLE OF CONTENTS

Item 7.01.   Regulation FD Disclosure.
Item 9.01.   Financial Statements and Exhibits.
SIGNATURES
EX-99.1 Press Release dated February 15, 2008

Table of Contents

Item 7.01.   Regulation FD Disclosure.
     On February 15, 2008, PAREXEL International Corporation (“PAREXEL”) announced that it has made a preliminary proposal to the Board of Directors of ClinPhone plc (“ClinPhone”), in relation to a potential offer by PAREXEL for the entire issued and to-be-issued share capital of ClinPhone. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
Item 9.01.   Financial Statements and Exhibits.
(d) Exhibits.
     
Exhibit No.
  Description
 
    
99.1
   Press release dated February 15, 2008.
SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
Date: February 15, 2008  PAREXEL International Corporation
 		  
  By:   /s/ Douglas A. Batt    
    Douglas A. Batt   
    Senior Vice President, General Counsel & Secretary